进入2月份，多家车企陆续披露1月份销量数据，行业运行态势逐步明朗。受春节临近、需求阶段性透支 等因素影响，1月份车市整体处于传统淡季，但新能源汽车板块仍保持较强韧性，头部车企凭借产品矩 阵和体系能力维持较高销量规模，行业分化特征进一步凸显。 具体来看，1月份，自主品牌阵营重新洗牌。上汽集团汽车销量为32.74万辆，同比增长23.94%，再度登 顶月销量榜首。紧随其后的是吉利汽车，汽车销量为27.02万辆，同比增长1%；昔日龙头比亚迪汽车销 量为21.01万辆，同比下滑30.11%。此外，奇瑞集团汽车销量为20.03万辆；广汽集团汽车销量为11.66万 辆，同比增长18.47%；长城汽车汽车销量为9.03万辆，同比增长11.59%；赛力斯汽车销量4.59万辆，同 比增长104.85%。 1月份，部分传统车企在新能源汽车与出口端的表现亦出现积极变化。例如，吉利汽车的海外出口总销 量同比实现翻倍增长；新能源汽车销量占销售总量的比例为46%，共销售12.43万辆，同比增长3%。上 汽通用汽车披露，1月份终端销量超5.1万辆，同比增长约8%，其中新能源车型销量同比增长接近90%， 出口销量同比增长超过一倍。奇瑞集团出口 ...

2026年1月，在政策切换与年终促销透支的双重作用下，国内车市经历深度调整。 据乘联分会初步推算，1月狭义乘用车零售市场规模约为180万辆，环比下降20.4%，同比微增0.3%。多家传统车 企和造车新品牌发布的销量数据也显示，今年1月汽车市场整体呈现销量环比下滑、同比上扬的局面。 上汽集团1月销量达32.74万辆，同比增长23.94%，为当月销量规模最高的车企。 吉利汽车集团1月乘用车销量达27.02万辆，同比增长1.29%，环比增长14.08%，成为目前唯一实现同环比正增长的 企业。 比亚迪1月销量国内下滑、海外增长。当月总销量约21万辆，其中海外市场销量超10万辆，同比增长51.47%。海 外市场的快速拓展正成为比亚迪重要的增长引擎。比亚迪品牌及公关部门总经理李云飞年初透露，公司计划在 2026年向中国以外地区销售130万辆汽车。 （文章来源：新京报） 新势力车企中，小米汽车1月交付量超3.9万辆，首次超越零跑汽车。赛力斯、极氪、蔚来1月销量同比分别增长 104.85%、99.7%和96.08%，成为当月表现亮眼的高增长梯队。 吉利汽车集团 14.08% 270167 1% 比亚迪 210051 -30. ...

Core Insights - The domestic automotive market in January 2026 experienced a significant adjustment due to policy changes and year-end promotions, with a retail market size of approximately 1.8 million vehicles, reflecting a month-on-month decline of 20.4% but a slight year-on-year increase of 0.3% [1] Group 1: Traditional Automakers - SAIC Motor Corporation achieved sales of 327,400 vehicles in January, marking a year-on-year increase of 23.94%, making it the top-selling automaker for the month [1] - Geely Automobile Group reported sales of 270,200 vehicles, with a year-on-year growth of 1.29% and a month-on-month increase of 14.08%, being the only company to show positive growth in both metrics [1] - BYD's total sales reached approximately 210,000 vehicles, with domestic sales declining but overseas sales exceeding 100,000 vehicles, reflecting a year-on-year growth of 51.47% [1] - Chery Group's total sales across five brands exceeded 200,000 vehicles, showing a year-on-year decline of 10.7% [2] - GAC Group's sales were 116,600 vehicles, with a year-on-year increase of 18.47% [2] - Great Wall Motors sold over 90,300 vehicles, achieving a year-on-year growth of 11.59% [2] Group 2: New Energy and Emerging Automakers - Xiaomi Automobile delivered over 39,000 vehicles in January, surpassing Leap Motor for the first time [2] - Emerging automakers such as Seres, Zeekr, and NIO reported year-on-year sales growth of 104.85%, 99.7%, and 96.08% respectively, indicating strong performance in the high-growth segment [2] - The sales data for several new energy vehicle companies showed significant fluctuations, with some experiencing declines while others achieved substantial growth [4]

2026年1月，在政策切换与年终促销透支的双重作用下，国内车市经历深度调整。 据乘联分会初步推算，1月狭义乘用车零售市场规模约为180万辆，环比下降20.4%，同比微增0.3%。多家传统车企和造车新品牌发布的销量数据也显示，今 年1月汽车市场整体呈现销量环比下滑、同比上扬的局面。 上汽集团1月销量达32.74万辆，同比增长23.94%，为当月销量规模最高的车企。 吉利汽车集团1月乘用车销量达27.02万辆，同比增长1.29%，环比增长14.08%，成为目前唯一实现同环比正增长的企业。 比亚迪1月销量国内下滑、海外增长。当月总销量约21万辆，其中海外市场销量超10万辆，同比增长51.47%。海外市场的快速拓展正成为比亚迪重要的增长 引擎。比亚迪品牌及公关部门总经理李云飞年初透露，公司计划在2026年向中国以外地区销售130万辆汽车。 新京报 业 贝壳财经 统筹 廖爱玲 6家自主车企2026年1月销量(辆) 0 O 上汽集团 SAIC 吉利汽车集团 比亚迪 奇瑞集团 *汽集团 长城汽车 部分新势力车企2026年1月销量(辆) ● O 赛力斯 小米 0 零跑 理想 (含乐道、萤火虫品牌) 蔚来 极氪 小鹏 岚图 . ...

证券研究报告 汽车 行业定期报告 hyzqdatemark 2026 年 02 月 02 日 投资评级： 看好（维持） 李泽 SAC：S1350525030001 lize@huayuanstock.com 秦梓月 SAC：S1350525070008 qinziyue@huayuanstock.com 联系人 板块表现： 主机厂原材料涨价后续影响分析 ——汽车行业周报（20260126-20260201） 投资要点： 请务必仔细阅读正文之后的评级说明和重要声明 证券分析师 2025Q4 以来碳酸锂、六氟磷酸锂等电池原材料及铜、铝等价格均出现上涨。2020 年以来汽车原材料价格的明显上涨主要分为两轮：第一轮为 2020 年（尤其 2020Q3 开始）~2022 年（主要截至 2022Q1），彼时汽车主要原材料价格出现普涨，其中碳 酸锂涨幅居前，电池级碳酸锂价格由 2020Q3 的平均 4 万元/吨涨至 2022Q4 的平均 55 万元/吨；第二轮则为 2025Q4 以来的碳酸锂、六氟磷酸锂等电池原材料及铜、铝 等价格的上涨，2026 年 1 月 28 日电池级碳酸锂、六氟磷酸锂、LME 铜现货结算价、 中国铜 ...

Investment Highlights - The article emphasizes a positive outlook for the passenger car sector, anticipating a recovery in demand in Q1 2026 due to the implementation of industry subsidy policies [3][8] - For the entire year, the focus is on domestic companies that are resilient to policy fluctuations and those with strong export capabilities, recommending companies like JAC Motors and Geely [3][8] Commercial Vehicle Insights - In 2025, the wholesale volume of heavy trucks reached 1.144 million units, a year-on-year increase of 26.8%, with domestic sales at 799,000 units, up 32.8% [4][26] - The article forecasts that heavy truck domestic sales in 2026 could reach 800,000 to 850,000 units, a 3% increase year-on-year, and continues to recommend leading companies in the sector [4][26] Bus Sector Update - The article notes that the 2026 vehicle replacement policy exceeded expectations, with a projected bus sales volume of 40,000 units in 2026, reflecting a 40% year-on-year increase [5][25] - It highlights the importance of focusing on leading bus manufacturers such as Yutong and King Long [5][25] Motorcycle Market Outlook - The motorcycle industry is expected to see total sales of 19.38 million units in 2026, a 14% increase year-on-year, with large-displacement motorcycles projected to reach 1.26 million units, up 31% [5][23] - The article recommends leading motorcycle manufacturers like Chunfeng Power and Longxin General [5][23] Performance Metrics - The article provides insights into the performance of various vehicle segments, noting that the passenger car index decreased by 4.8% this week, while the commercial vehicle index increased by 2.2% [12][18] - Key individual stock performances are highlighted, with NIO showing a 3.2% increase and Seres experiencing an 11.8% decline [12][18]

Group 1 - The core announcement is the upcoming launch of the new model AITO Wenjie M6, as stated by Huawei's executive Yu Chengdong, indicating a focus on the younger market segment [1][4]. - The AITO Wenjie brand aims to complete its product matrix with the introduction of the M6, which is part of a strategy to target high-end family vehicles in collaboration with Seres [4]. - AITO Wenjie achieved a significant milestone with the production of its one-millionth vehicle, aiming to reach the next million in just two years, building on a five-year timeline for the first million [4]. Group 2 - In January 2026, AITO Wenjie reported a total delivery of 57,915 vehicles, reflecting a year-on-year growth of 65.6% [5]. - The M6 model has been undergoing winter testing, generating considerable interest and speculation about its design and technology [3]. - The brand's strategy includes a comprehensive product lineup, with the M6 being a key addition to enhance its market presence [4].

Group 1 - The Hong Kong stock market continues its strong momentum into 2026, with 13 companies successfully listed and raising over 33 billion HKD as of January 28 [1][4] - In 2025, the Hong Kong stock market saw a significant recovery, with 119 new IPOs raising approximately 285.8 billion HKD, marking a return to the top of the global IPO fundraising rankings [3] - Chinese securities firms have become key players in the Hong Kong IPO market, capturing 56.15% of the market share among the top ten underwriters [3] Group 2 - The 2025 IPO landscape was dominated by mainland enterprises, which accounted for over 90% of the total IPOs, with major projects from companies like CATL and Zijin Mining [6][7] - The A+H listing model has gained traction, with 19 A-share companies raising about 140 billion HKD through this method, representing nearly half of the total IPO fundraising [6] - Chinese securities firms have shown unique advantages in A+H projects, achieving over 90% market share in this segment [7] Group 3 - The new economy sectors, particularly technology and healthcare, have become core areas for IPOs, with significant increases in listings and fundraising in these fields [8][9] - The Hong Kong Stock Exchange has optimized its listing mechanisms for biotech and specialized technology companies, attracting nearly 100 related firms by the end of 2025 [9] - Chinese securities firms are adapting their strategies to meet the specialized financing needs of new economy enterprises, establishing dedicated teams for industry-specific services [9] Group 4 - The growth of the Hong Kong market is supported by favorable policies, including measures from the China Securities Regulatory Commission to facilitate mainland companies' listings [11] - Despite the dominance of Chinese securities firms, competition from international investment banks remains a challenge, particularly in high-end cross-border financing [10] - Chinese securities firms are building a comprehensive competitive framework that includes service, pricing, and compliance to enhance their market position [12] Group 5 - Chinese securities firms are deepening their international collaborations and enhancing their global business capabilities, with several firms announcing significant capital increases for their Hong Kong subsidiaries [16] - The capital infusion aims to support the development of overseas businesses and enhance service capabilities [16][17] - Chinese securities firms are expanding their global footprint, with strategies targeting Southeast Asia and Europe, leveraging their regional advantages [17]

Core Viewpoint - The article discusses the dramatic decline of Zhifei Biological Products Co., Ltd., a leading vaccine manufacturer in China, and the subsequent shift in wealth dynamics in Chongqing, highlighting the fall of the Jiang Rensheng family from the top of the wealth hierarchy due to significant financial losses and the rise of new business leaders in the region [4][5][19]. Group 1: Company Performance and Financial Decline - Zhifei Biological announced a projected net loss of 10.698 billion to 13.726 billion yuan for 2025, representing a year-on-year decline of 630% to 780% [4][5]. - The company's revenue in 2023 reached 52.92 billion yuan, with a net profit of 7.915 billion yuan, but the revenue is expected to plummet to 26.07 billion yuan in 2024, a nearly 75% decrease [14]. - The reliance on agency business for 88.84% of total revenue has left Zhifei vulnerable, leading to a severe profitability crisis as market conditions shifted [14][25]. Group 2: Wealth Dynamics and Family Impact - The Jiang Rensheng family's wealth has decreased from 140 billion yuan in 2021 to 42 billion yuan in 2025, a loss of nearly 100 billion yuan, equivalent to the combined market value of two leading listed companies in Chongqing [16]. - The stock market valuation of Zhifei Biological has dropped from 360 billion yuan to 41 billion yuan, exacerbating liquidity and asset impairment pressures [16]. - The family is now resorting to asset pledges and loans to manage financial strain, marking a significant shift from their previous status as a dominant business family [18][19]. Group 3: Market Competition and Industry Trends - The vaccine industry is experiencing intensified competition as domestic vaccine manufacturers improve their R&D capabilities, leading to a breakdown of foreign monopolies [25]. - The introduction of domestic HPV vaccines has triggered price wars, significantly impacting Zhifei's market position and profitability [13][25]. - The article emphasizes the need for companies to transition from reliance on external resources to developing core technologies to survive in a changing market landscape [26].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 賽力斯集團股份有限公司 呈交日期: 2026年2月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | A | | | 於香港聯交所上市 (註1) | | 否 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 601127 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,633,366,086 | RMB | | 1 | RMB | | 1,633,366,086 | | 增加 / 減少 (-) | | | | | | | RMB | | | | 本月底結存 | | | 1,633,366,086 | RMB | | | 1 RMB | | 1,633,366,086 | | 2. 股份分類 ...